Plywood from Asia 'Hurting' US—Tariffs Stay, Yawn
Published Date: 9/9/2026
Notice
Summary
The U.S. has found that imports of hardwood and decorative plywood from China, Indonesia, and Vietnam are hurting American businesses because they're being sold unfairly cheap or getting government help. As a result, the government will keep rules in place to protect U.S. plywood makers, which could mean extra costs for importers starting soon. This helps American companies stay strong and fair in the market.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
US Plywood Industry Found Injured
On September 4, 2026 the U.S. International Trade Commission determined that U.S. producers are materially injured by imports of hardwood and decorative plywood from China, Indonesia, and Vietnam. The finding applies to hardwood and decorative plywood (excluding all softwood structural plywood) and follows Commerce findings that those imports were subsidized or sold at less than fair value.
Orders' Remedial Effect Affirmed
The Commission found that imports subject to Commerce's affirmative critical circumstances determinations are not likely to seriously undermine the remedial effect of the countervailing orders on hardwood and decorative plywood from China and Vietnam and the antidumping duty order on hardwood and decorative plywood from China. This finding was included in the Commission's determinations filed September 4, 2026.
Softwood Structural Plywood Probe Ended
The Commission terminated investigations into softwood structural plywood (including stamped and certified varieties) from China, Indonesia, and Vietnam on the grounds of negligibility. That termination was announced in the Commission's determinations filed September 4, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18302, Certain Glow Fish Tape Systems, Safety Helmet Systems, and Components Thereof; Notice of a Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on the Issues Under Review, Remedy, Bond, and the Public Interest
Notice is hereby given that the U.S. International Trade Commission ("the Commission") has determined to review in part a final initial determination ("FID") issued by the presiding chief administrative law judge's ("CALJ") in the above-captioned investigation finding a violation of section 337 of the Tariff Act of 1930, and to solicit briefing on the issues under review as well as remedy, bonding, and the public interest.
2026-18379, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from trinamiX about some mobile devices and parts, pointing fingers at Apple. They’re asking for rules to stop these products from being sold in the U.S. while the case is reviewed. If you’re interested, you can share your thoughts soon—this could shake up the tech world and affect sales during the next two months.
2026-18195, L-Lysine From China
2026-18101, Certain Photodynamic Therapy Systems, Components Thereof, and Pharmaceutical Products Used in Combination With the Same; Notice of the Commission's Determination To Lift the Partial Suspension of Enforcement of the Remedial Orders as to U.S. Patent No. 11,697,028
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to grant a request submitted by Sun Pharmaceutical Industries, Inc. ("Complainant") of Princeton, New Jersey to lift the partial suspension of enforcement of the limited exclusion order ("LEO") and cease and desist orders ("CDOs") as to U.S. Patent No. 11,697,028 ("the '028 patent").
2026-18027, Certain Mobile Electronic Devices; Notice of a Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on the Issues Under Review and on Remedy, The Public Interest, and Bonding
The U.S. International Trade Commission is rechecking part of a decision about certain mobile electronic devices that might have broken patent rules. This affects companies importing or selling these devices in the U.S., with possible changes to what’s allowed and how much money might be involved. They’re asking for opinions on fixes, public impact, and money guarantees soon, so stay tuned!
2026-18005, Welded Line Pipe From South Korea and Turkey; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up reviews to decide if special taxes on welded line pipe from South Korea and Turkey should stay or go. This affects pipe makers and importers, with decisions expected soon that could impact prices and trade rules. The review started after U.S. companies showed strong interest, while foreign responses were weak.
Previous / Next Documents
Previous: 2026-18365, Notice of Final Federal Agency Actions on Proposed Highway Project in Colorado
This notice announces actions taken by the FHWA that are final. The actions relate to a proposed highway project, I-270 Corridor Improvements Project from I-25 to I-70 in the City of Commerce City, Adams County and City and County of Denver, Colorado, FHWA Project Number STU 2706-046, Colorado Department of Transportation (CDOT) Number 25611.
Next: 2026-18368, Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates; Guidance for Industry; Availability
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a guidance for industry titled "Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates." This guidance describes the FDA's regulatory and enforcement priorities regarding the compounding of certain starter parenteral nutrition drug products for neonates by outsourcing facilities and by State-licensed pharmacies and Federal facilities that are not registered with FDA as outsourcing facilities. This guidance is being published for immediate implementation due to the expected market exit of the predominant source of certain starter parenteral nutrition drug products for neonates in the United States.